Development and validation of a prediction model for acute kidney injury in cirrhosis with normal serum creatinine levels [0.03%]
正常血清肌酐水平的肝硬化患者急性肾损伤预测模型的开发和验证
Shenglong Lin,Wenhai Ke,Rong Wang et al.
Shenglong Lin et al.
Introduction and objectives: Acute kidney injury (AKI) is a serious complication in decompensated cirrhosis (DC). Conventional kidney function markers, including serum creatinine (sCr) and estimated glomerular filtration ...
The impact of early allograft dysfunction severity on graft and recipient outcomes in pediatric liver transplantation [0.03%]
儿童肝移植中同种异体移植物功能障碍严重程度对移植物和受者结局的影响
Weiming He,Xiaoke Dai,Bingqian Tan et al.
Weiming He et al.
Introduction and objectives: Early allograft dysfunction (EAD) substantially compromises graft and recipient outcomes; the clinical consequences of EAD vary according to severity. Research focusing on EAD in pediatric liv...
Predictors of recompensation in immunosuppressive therapy for biopsy-proven autoimmune hepatitis patients with decompensated cirrhosis [0.03%]
自身免疫性肝炎肝硬化的免疫抑制治疗复发的影响因素分析
Yujie Zhang,Ruoting Men,Yi Shen et al.
Yujie Zhang et al.
Introduction and objectives: The potential for recompensation in treatment-naïve patients with autoimmune hepatitis (AIH) and decompensated cirrhosis, per Baveno VII criteria, remains underexplored. This study aimed to i...
Challenges and adherence to hepatocellular carcinoma surveillance in patients with advanced chronic liver disease [0.03%]
晚期慢性肝病患者肝细胞癌筛查的挑战及依从性研究
Luís Neves da Silva,Elisabete Cerqueira,Joana Freitas Ribeiro et al.
Luís Neves da Silva et al.
Introduction and objectives: Hepatocellular carcinoma (HCC) is a major global health issue in patients with advanced chronic liver disease (ACLD). Although guidelines recommend biannual ultrasound surveillance for eligibl...
Development and validation of the HABIT score: a practical and robust tool to predict hepatic steatosis using HbA1c, BMI, and triglycerides in patients with unexplained elevated liver enzymes [0.03%]
HABIT评分的建立和验证：一种实用而稳健的工具，用于预测不明原因肝酶升高的患者的肝脂肪变性风险，使用HbA1c、BMI和甘油三酯评估
Eike Humbert,Verena Wilkens,Semjon Bugaichuk et al.
Eike Humbert et al.
Introduction and objectives: Unexplained elevated liver enzymes (ELE) are common and often linked to metabolic dysfunction-associated steatotic liver disease (MASLD). Diagnosis in primary care is difficult due to limited ...
The association of frailty with cardiovascular diseases and mortality in metabolic dysfunction-associated steatotic liver disease [0.03%]
代谢功能障碍相关肝脂变性疾病患者衰弱与心血管疾病和死亡率的相关性研究
Fuyi Ma,Huanyu Wang,Kang Wan et al.
Fuyi Ma et al.
Introduction and objectives: Frailty is highly prevalent in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD). However, the extent to which frailty influences cardiovascular disease (CVD) i...
Comment on "Serum IL-6 is a prognostic biomarker for advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab" [0.03%]
关于“血清IL-6是接受阿特珠单抗和贝伐珠单抗治疗的晚期肝细胞癌患者的预后生物标志物”的评论
Ningbo Xiao,Jinliang Dong,Qiujing Wang
Ningbo Xiao
Digital twin frameworks for Hepatitis C: Toward predictive, and personalised management [0.03%]
数字孪生框架在丙型肝炎治疗中的应用：迈向预测性和个性化管理
Ruqaiyyah Siddiqui,Naveed Ahmed Khan
Ruqaiyyah Siddiqui
Despite the availability of antivirals, Hepatitis C remains a major global public health challenge, with over 50 million people living with chronic infection and many remaining undiagnosed or untreated. Transmission persists in marginalised...
Mesencephalic astrocyte-derived neurotrophic factor (MANF): a context-dependent therapeutic regulator and potential biomarker in liver diseases [0.03%]
中脑星形胶质细胞源性神经生长因子（MANF）：一种依情境调控的治疗调节因子和潜在生物标志物在肝病中的作用
Yu Liu,Hao-Wen Wang,Li-Jun Zhang et al.
Yu Liu et al.
Mesencephalic astrocyte-derived neurotrophic factor (MANF) is a highly conserved protein that plays crucial roles in cellular stress responses and exerts profound impacts on multiple diseases. Accumulating evidence demonstrates that MANF is...
Fibulin-3 as a reliable biomarker of fibrosis in obese subjects with metabolic dysfunction-associated steatotic liver disease [0.03%]
肥胖合并代谢功能障碍相关性脂肪肝病患者血清FBLN3水平与肝纤维化的关系
Allen Anthony Laraño,Silvia Palmisano,Deborah Bonazza et al.
Allen Anthony Laraño et al.
Introduction and objectives: Metabolic dysfunction-associated steatotic liver disease (MASLD) affects about one-quarter of adults worldwide, and liver fibrosis is its strongest predictor of liver-related morbidity and mor...